News & Resources
IQuity Research Unveils Potential $18 Billion in Health Plan Cost-Savings and Demonstrates Effectiveness of Identifying At-Risk Autoimmune Disease Patients
IQuity announced that the company was published in a peer-reviewed article in the Journal of Clinical Medicine. This work is one of the first comprehensive overviews of prevalence, clinical characteristics, challenges, and financial impacts of autoimmune diseases and related disorders (multiple sclerosis, ulcerative colitis, Crohn's disease and rheumatoid arthritis, irritable bowel syndrome and fibromyalgia syndrome). These six conditions alone affect approximately 60 million people at an estimated cost to diagnose and treat of $90B annually. [...]
IQuity builds first data analytics platform to help payers find and fix their addressable autoimmune disease risks
Nashville start-up IQuity recently asked themselves a key question: “How can we leverage our data science [...]
IQuity Introduces Healthcare Analytics Platform
Machine learning platform predicts, detects and monitors chronic disease across patient populations. Former WPC Healthcare/Intermedix executives, Ray Guzman and Damian Mingle, named advisors for new platform.
AI Experts Advising IQuity
The leaders of local health care data company, IQuity, have recruited two well-known local tech [...]
As Seen In
News
Data Analytics Holds Promise of Dramatically Improving Outcomes for Patients with Autoimmune Disease.
The movement to embrace predictive analytics, which has been gathering steam over the past several years, will be especially important as hospitals seek to improve their capabilities to forecast, detect and monitor chronic conditions, especially autoimmune diseases. Read the Article
Predictive Analytics: How Big Data Will Improve Outcomes and Efficiencies in Diagnosing and Treating Patients
A growing body of research in the exciting field of predictive and prescriptive analytics suggests that if you input large datasets—drawn from millions of healthcare claims or electronic medical records, for example—sophisticated algorithms can identify patterns that deliver meaningful diagnostic information for patients with a wide range of conditions. These [...]
MS & AI with Dr. Chase Spurlock, CEO of IQuity
Artificial intelligence is changing healthcare. And that might include how MS will be diagnosed, treated, and managed. It's even beginning to impact the way some MS research is being conducted. Chase Spurlock, PhD, founder and CEO of IQuity talks about how IQuity is using its expertise in machine learning to [...]
Publications
Illuminating an Invisible Epidemic: A Systematic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes
A long sought-after goal across a wide range of healthcare specialties is to devise strategies that enhance patient care and simultaneously reduce expenses. Inflammatory diseases and chronic syndromes currently impose an immense social and economic burden on society in terms of both direct and indirect healthcare costs. While published annual [...]
Blog
Illuminating an Invisible Epidemic: Addressing Cost Drivers in Diagnosis and Treatment of Autoimmune Diseases and Disorders
Everyone knows at least one person with an autoimmune disease or disorder and just may not know it. Even if you think you don’t, you most likely do, considering autoimmune diseases affect approximately 50 million Americans while cancer affects 15 million. Both diseases substantially impact society, but how do we [...]